SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-106419
Filing Date
2024-09-13
Accepted
2024-09-13 16:50:17
Documents
1
Period of Report
2024-09-11

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5700
  Complete submission text file 0000950170-24-106419.txt   7351
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MEREO BIOPHARMA 1 CAVENDISH PLACE LONDON X0 W1G 0QF
Business Address
Fox Christine Ann (Reporting) CIK: 0002005755 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38452 | Film No.: 241298403